News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
2551
Sources here
18
Companies here
28
Search results Stored financial headlines

Active search

2551 matching headlines

Ticker or company: LIFEMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Achieve Life Sciences, Inc. (NASDAQ:ACHV): Is Breakeven Near?

Achieve Life Sciences, Inc. (NASDAQ:ACHV) is a late-stage pharmaceutical company developing cytisinicline for nicotine independence. Despite widening losses to US$114m, analysts project the company to reach breakeven by 2028, with an anticipated 69% year-on-year growth. The company currently has negative equity on its balance …

ACHV main company
Sharemaestro market context Trend signal active 52 weeks +159.9% ACHV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MetLife (MET) details $13.1M in Form 13F holdings in combination report

MetLife Inc. (MET) has filed a Form 13F Combination Report detailing its equity holdings. The report summarizes 6 portfolio entries with an aggregate reported value of $13,089,220, representing Section 13(f) securities managed by its investment subsidiaries. MetLife clarifies that it disclaims direct investment discretion, …

MET main company
Sharemaestro market context Trend signal active 52 weeks +22.5% · Next-week setup positive 55.9% MET stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Assenagon Asset Management S.A. Reduces Position in Integra LifeSciences Holdings Corporation $IART

Assenagon Asset Management S.A. significantly reduced its stake in Integra LifeSciences Holdings Corporation by 66.3% in the second quarter of 2026, selling over 276,000 shares. Despite this, other institutional investors like Rubric Capital Management LP and Paradigm Capital Management Inc. NY increased their holdings. …

IART main company
Sharemaestro market context Trend signal active 52 weeks +23.4% IART stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why SELLAS (SLS) Posted a Wider Net Loss but a Narrower Per-Share Loss This Quarter

SELLAS Life Sciences Group (SLS) reported a wider net loss in Q2 2026 but a narrower loss per share, driven by increasing expenses related to late-stage oncology programs. The company's investment narrative continues to revolve around the success of its Phase 3 REGAL trial …

SLS main company
Sharemaestro market context Trend signal active 52 weeks +569.1% SLS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages

LifeMD, Inc. (NASDAQ:LFMD) has received a "Moderate Buy" consensus rating from ten brokerages, with an average 12-month price target of $7.57. Despite this, the company reported a slight miss on quarterly earnings and revenue expectations, posting a loss of $0.16 per share and $47.28 …

LFMD main company
Sharemaestro market context Price below Trend Line 52 weeks -45.5% · Next-week setup negative 42.8% LFMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sun Life (SLF) Q2 2026 Earnings Call Transcript

Sun Life Financial (SLF) reported strong Q2 2026 results with double-digit underlying EPS growth and increased earnings across all business segments, including record income in Canada and significant growth in Asia and the U.S. medical stop loss market. The company highlighted advancements in AI, …

SLF main company
Sharemaestro market context Trend signal active 52 weeks +44.0% SLF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MetLife’s Q2 Earnings Call: Our Top 5 Analyst Questions

MetLife's Q2 Earnings Call: Our Top 5 Analyst Questions MetLife's second quarter results were marked by broad-based earnings growth, with market participants rewarding the company's performance as shares rose notably after the announcement. Management attributed the positive momentum to strong underwriting across all segments, …

MET main company MET main company METL main company
Sharemaestro market context Trend signal active 52 weeks +15.9% MET stored weekly price path from 22 Aug 2025 to 14 Aug 2026

WAVE Life Sciences (NASDAQ:WVE) Director Adrian Rawcliffe Sells 12,700 Shares

WAVE Life Sciences (NASDAQ:WVE) Director Adrian Rawcliffe sold 12,700 shares of the company's stock for approximately $67,183. The sale occurred on August 12th when shares were trading at $5.29. Following the transaction, WVE shares fell to $5.20, near their 12-month low, and the company …

WVE main company
Sharemaestro market context Price below Trend Line 52 weeks -46.7% WVE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insider Selling: WAVE Life Sciences (NASDAQ:WVE) Director Sells $42,070.00 in Stock

WAVE Life Sciences (NASDAQ:WVE) Director Heidi Wagner sold 7,000 shares of the company's stock for $42,070, reducing her position by 13.48%. The sale occurred amidst weak trading and quarterly results, with WVE shares near their 52-week low and the company reporting a loss and …

WVE main company
Sharemaestro market context Price below Trend Line 52 weeks -46.7% WVE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wave Life Sciences (WVE) director’s 3,864-share tax sale under 10b5-1 plan

Ken Takanashi, a director at Wave Life Sciences (WVE), sold 3,864 shares of common stock on August 11, 2026, at a weighted-average price of $6.01 per share. This sale was made under a Rule 10b5-1 trading plan solely to cover tax obligations arising from …

WVE main company
Sharemaestro market context Price below Trend Line 52 weeks -46.7% WVE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

FitLife outlines plan to launch at least 4 new Irwin products per quarter beginning in 2027 amid supply chain and Amazon initiatives

Earnings Call Insights: FitLife Brands (FTLF) Q2 2026 MANAGEMENT VIEW * "For the second quarter of 2026, total revenue was $26.5 million, an increase of 65% compared to the same quarter last year" (Chairman & CEO Dayton Judd), and he said the increase was …

FTLF main company
Sharemaestro market context Price below Trend Line 52 weeks -36.5% · Next-week setup negative 43.1% FTLF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context